Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) EV/Sales
As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a EV/Sales of 1.7×. Over the past ten years it has ranged from 0.7× (November 2022) to 2.0× (September 2018); the current reading is higher than 81% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.5× | (0.88%) |
| FY2024 | 1.5× | 35.80% |
| FY2023 | 1.1× | 32.33% |
| FY2022 | 0.8× | (41.21%) |
| FY2021 | 1.4× | (18.27%) |
| FY2020 | 1.8× | 30.40% |
| FY2019 | 1.3× | 17.15% |
| FY2018 | 1.1× | (29.58%) |
| FY2017 | 1.6× | 62.03% |
| FY2016 | 1.0× | 5.04% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.4× | (8.06%) |
| Jun 2026 | 1.5× | (0.20%) |
| Mar 2026 | 1.5× | 1.19% |
| Dec 2025 | 1.5× | (10.68%) |
| 37 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 1.6× |
| PHG Koninklijke Philips N.V. | 1.7× |
| GEHC GE HealthCare Technologies Inc. compare | 2.1× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.2× |
| BSX Boston Scientific Corporation compare | 3.6× |
| STE STERIS plc compare | 4.2× |
| DXCM DexCom, Inc. compare | 6.2× |
| EW Edwards Lifesciences Corporation compare | 8.2× |
| GKOS Glaukos Corporation compare | 18.8× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement